Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As investors pivot away from high-flying tech, the financial sector could offer underappreciated value. This guide ex...
When a bank’s CEO retiires and a director sells shares, investors take notice. This article breaks down what that mov...
A viral Reddit post argues you can reach a $1.2 million nest egg by age 67 with no additional contributions, starting...
Geopolitical turmoil and potential chokepoint disruptions raise the odds of a renewed oil shock. Markets bracing $100...
Palantir stock investors just got new cues from the Street. This guide explains what the headlines might mean, how to...
The U.S. DOJ moves to retry Tornado Cash developer Roman Storm on key charges in SDNY, aiming to resolve unresolved c...
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
Nvidia’s new AI architectures debuted at GTC 2026, signaling a longer-term AI infrastructure push. Here’s what that m...
As U.S. recession odds rise, XRP could see amplified volatility driven by flow dynamics and policy timing. Here is ho...
Delivery drivers say rising fuel costs are cutting take-home pay, underscoring how higher prices squeeze people who r...
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...